EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen

Ying Zhu, Yong Zhou, Xiaonan Ma iD, Zhenduo Duan, Hong Xu, Yuanyuan Li, Yunfan Kong iD, Lei Yang iD, Xiaofei Xin iD

Pharmaceutics · 20.02.2025 · 17 (3) · 283

DOI: 10.3390/pharmaceutics17030283 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.02.2025. Verfasst von Ying Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, National Center of Technology Innovation for Biopharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic inflammatory disease with a complex pathogenesis, influenced by various factors involving environment, genes, and immunity. The main symptoms of psoriasis include erythema, scales, itching, etc. At present, therapeutic drugs for psoriasis are continually evolving towards enhancing treatment efficacy and reducing side effects. Firstly, the pathogenesis and characteristics of psoriasis were summarized. Then, the types and benefits of topical therapy were introduced, such as the aspects of avoiding systemic toxic effects, first pass effect, and gastrointestinal reactions with accelerating the onset time of the drugs and improving its efficacy, and were compared to systemic drugs. In the case of methotrexate, cyclosporin A, Janus kinase (JAK) inhibitors, and phosphodiesterase-4 (PDE-4) inhibitors, this review had a further discussion on the improvement and translation of these molecules from systemic therapy to topical therapy in clinical practice. To further augment the limitation of skin permeability, nanotechnology and novel topical drug delivery system including nanomedicines, hydrogels, ionic liquids, and microneedles were elaborated for psoriasis management. Also, exploration of topical targeting pathogenic genes through small interfering RNA (siRNA) using nanoparticles and ionic liquids (ILs) is of great significance for long-term treatment in psoriasis. Taken together, the development of numerous topical delivery platforms is expected to achieve enhanced penetration, and precise and efficient delivery of small molecule and RNA interference (RNAi) therapeutics in psoriasis with clinical translation prospects.

Schlagwörter

Stichwörter der Autor:innen

hydrogelionic liquidmicroneedlesnanomedicinesnovel therapeuticspsoriasistopical treatment

Autor:innen und Institutionen

  • Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
  • National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luoyu Road, Wuhan 430074, China.
  • The Public Laboratory Platform of China Pharmaceutical University, Nanjing 210009, China.
  • The F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China.

ORCID-Profile: Xiaonan Ma, Yunfan Kong, Lei Yang, Xiaofei Xin

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • National Center of Technology Innovation for Biopharmaceuticals

Zitieren

APA

Zhu, Y., Zhou, Y., Ma, X., Duan, Z., Xu, H., Li, Y., Kong, Y., Yang, L., & Xin, X. (2025). Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen. Pharmaceutics, 17(3), 283. https://doi.org/10.3390/pharmaceutics17030283

Vancouver

Zhu Y, Zhou Y, Ma X, Duan Z, Xu H, Li Y, et al. Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen. Pharmaceutics. 2025;17(3):283. doi:10.3390/pharmaceutics17030283

BibTeX
@article{Zhu2025,
  author = {Zhu, Ying and Zhou, Yong and Ma, Xiaonan and Duan, Zhenduo and Xu, Hong and Li, Yuanyuan and Kong, Yunfan and Yang, Lei and Xin, Xiaofei},
  title = {Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {283},
  doi = {10.3390/pharmaceutics17030283}
}
Kostenlos starten →